Table of Contents

2018-2023 Global Oral Vaccine Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Oral Vaccine Consumption 2013-2023
  • 2.1.2 Oral Vaccine Consumption CAGR by Region
• 2.2 Oral Vaccine Segment by Type
  • 2.2.1 Rotavirus Vaccine
  • 2.2.2 Cholera Vaccine
  • 2.2.3 Oral Polio Vaccine
  • 2.2.4 Others
• 2.3 Oral Vaccine Consumption by Type
  • 2.3.1 Global Oral Vaccine Consumption Market Share by Type (2013-2018)
  • 2.3.2 Global Oral Vaccine Revenue and Market Share by Type (2013-2018)
  • 2.3.3 Global Oral Vaccine Sale Price by Type (2013-2018)
• 2.4 Oral Vaccine Segment by Application
  • 2.4.1 Public
  • 2.4.2 Private
• 2.5 Oral Vaccine Consumption by Application
  • 2.5.1 Global Oral Vaccine Consumption Market Share by Application (2013-2018)
  • 2.5.2 Global Oral Vaccine Value and Market Share by Application (2013-2018)
  • 2.5.3 Global Oral Vaccine Sale Price by Application (2013-2018)

3 Global Oral Vaccine by Players

• 3.1 Global Oral Vaccine Sales Market Share by Players
  • 3.1.1 Global Oral Vaccine Sales by Players (2016-2018)
  • 3.1.2 Global Oral Vaccine Sales Market Share by Players (2016-2018)
• 3.2 Global Oral Vaccine Revenue Market Share by Players
  • 3.2.1 Global Oral Vaccine Revenue by Players (2016-2018)
  • 3.2.2 Global Oral Vaccine Revenue Market Share by Players (2016-2018)
• 3.3 Global Oral Vaccine Sale Price by Players
• 3.4 Global Oral Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Oral Vaccine Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Oral Vaccine Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Oral Vaccine by Regions

• 4.1 Oral Vaccine by Regions
  • 4.1.1 Global Oral Vaccine Consumption by Regions
  • 4.1.2 Global Oral Vaccine Value by Regions
• 4.2 Americas Oral Vaccine Consumption Growth
• 4.3 APAC Oral Vaccine Consumption Growth
• 4.4 Europe Oral Vaccine Consumption Growth
• 4.5 Middle East & Africa Oral Vaccine Consumption Growth

5 Americas

• 5.1 Americas Oral Vaccine Consumption by Countries
  • 5.1.1 Americas Oral Vaccine Consumption by Countries (2013-2018)
  • 5.1.2 Americas Oral Vaccine Value by Countries (2013-2018)
• 5.2 Americas Oral Vaccine Consumption by Type
• 5.3 Americas Oral Vaccine Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Oral Vaccine Consumption by Countries
  • 6.1.1 APAC Oral Vaccine Consumption by Countries (2013-2018)
  • 6.1.2 APAC Oral Vaccine Value by Countries (2013-2018)
• 6.2 APAC Oral Vaccine Consumption by Type
• 6.3 APAC Oral Vaccine Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Oral Vaccine by Countries
  • 7.1.1 Europe Oral Vaccine Consumption by Countries (2013-2018)
  • 7.1.2 Europe Oral Vaccine Value by Countries (2013-2018)
• 7.2 Europe Oral Vaccine Consumption by Type
• 7.3 Europe Oral Vaccine Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Oral Vaccine by Countries
  • 8.1.1 Middle East & Africa Oral Vaccine Consumption by Countries (2013-2018)
  • 8.1.2 Middle East & Africa Oral Vaccine Value by Countries (2013-2018)
• 8.2 Middle East & Africa Oral Vaccine Consumption by Type
• 8.3 Middle East & Africa Oral Vaccine Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.2 Oral Vaccine Distributors
• 10.3 Oral Vaccine Customer

11 Global Oral Vaccine Market Forecast

• 11.1 Global Oral Vaccine Consumption Forecast (2018-2023)
• 11.2 Global Oral Vaccine Forecast by Regions
  • 11.2.1 Global Oral Vaccine Forecast by Regions (2018-2023)
  • 11.2.2 Global Oral Vaccine Value Forecast by Regions (2018-2023)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Oral Vaccine Forecast by Type
• 11.8 Global Oral Vaccine Forecast by Application

12 Key Players Analysis

• 12.1 Merck
  • 12.1.1 Company Details
  • 12.1.2 Oral Vaccine Product Offered
  • 12.1.3 Merck Oral Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.1.4 Main Business Overview
  • 12.1.5 Merck News
• 12.2 GSK
  • 12.2.1 Company Details
  • 12.2.2 Oral Vaccine Product Offered
  • 12.2.3 GSK Oral Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.2.4 Main Business Overview
  • 12.2.5 GSK News
• 12.3 Sanofi
  • 12.3.1 Company Details
  • 12.3.2 Oral Vaccine Product Offered
  • 12.3.3 Sanofi Oral Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.3.4 Main Business Overview
  • 12.3.5 Sanofi News
• 12.4 Lanzhou Institute
  • 12.4.1 Company Details
  • 12.4.2 Oral Vaccine Product Offered
  • 12.4.3 Lanzhou Institute Oral Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.4.4 Main Business Overview
  • 12.4.5 Lanzhou Institute News
• 12.5 Serum Institute
  • 12.5.1 Company Details
  • 12.5.2 Oral Vaccine Product Offered
  • 12.5.3 Serum Institute Oral Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.5.4 Main Business Overview
  • 12.5.5 Serum Institute News
• 12.6 Valneva
  • 12.6.1 Company Details
  • 12.6.2 Oral Vaccine Product Offered
  • 12.6.3 Valneva Oral Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.6.4 Main Business Overview
  • 12.6.5 Valneva News
• 12.7 Shanghai United Cell
  • 12.7.1 Company Details
  • 12.7.2 Oral Vaccine Product Offered
  • 12.7.3 Shanghai United Cell Oral Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.7.4 Main Business Overview
  • 12.7.5 Shanghai United Cell News
• 12.8 Bibcol
  • 12.8.1 Company Details
  • 12.8.2 Oral Vaccine Product Offered
  • 12.8.3 Bibcol Oral Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.8.4 Main Business Overview
  • 12.8.5 Bibcol News
• 12.9 PaxVax
  • 12.9.1 Company Details
  • 12.9.2 Oral Vaccine Product Offered
  • 12.9.3 PaxVax Oral Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.9.4 Main Business Overview
  • 12.9.5 PaxVax News
• 12.10 Vabiotech
  • 12.10.1 Company Details
  • 12.10.2 Oral Vaccine Product Offered
  • 12.10.3 Vabiotech Oral Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.10.4 Main Business Overview
  • 12.10.5 Vabiotech News
• 12.11 Tiantan Biological
• 12.12 EuBiologics
• 12.13 Panacea Biotec Ltd
• 12.14 Bio-Med
• 12.15 Halfkin Bio-Pharmaceuticals

13 Research Findings and Conclusion

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

According to this study, over the next five years the Oral Vaccine market will register a CAGR in terms of revenue, the global market size will reach US$ million by 2023, from US$ million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Oral Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Vaccine market by product type, application, key manufacturers and key regions and countries.

This study considers the Oral Vaccine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7.
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Others
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 11.8.
Public
Private

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Oral Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Oral Vaccine market by identifying its various subsegments.
Focuses on the key global Oral Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oral Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Oral Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.